Low levels of CRP (0.1~10mg/L) are closely related to the occurrence of cardiovascular disease, and are biomarkers of cardiovascular inflammatory lesions. This level of C-reactive protein is also known as the hypersensitive C-reactive protein (hs-CRP). The individual's CRP basal level is closely related to the future cardiovascular disease. CRP may be a more effective and independent predictor of cardiovascular disease than low-density lipoprotein cholesterol, which may increase the prognostic value of lipid tests, metabolic syndrome, and Framingham risk scores.
ABOUT US
Joinstar Biomedical Technology Co.,Ltd was founded in December 2010. As a biomedical high-tech company which covers whole industrial chain, we are mainly engaged in medical in vitro diagnosis products.
PRODUCTS
Focusing on innovative markers and POCT applications in all fields, it provides a total solution for the disease-centered POCT technology platform, quality control, and clinical applications.
INNOVATIVE SERVICES
Create a new medical model ,namely ‘doctors as the core , patients as the center’, and constantly provide practical models for innovative services.
CONTACT US
Create a new medical model ,namely ‘doctors as the core , patients as the center’, and constantly provide practical models for innovative services.
